Asset Details
Do you wish to reserve the book?
Gefitinib plus docetaxel in non-small-cell lung cancer/Authors' reply
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Gefitinib plus docetaxel in non-small-cell lung cancer/Authors' reply
Do you wish to request the book?
Gefitinib plus docetaxel in non-small-cell lung cancer/Authors' reply
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Gefitinib plus docetaxel in non-small-cell lung cancer/Authors' reply
2009
Overview
[...] this analysis would exclude different numbers and types of patients from each group and would not be a balanced randomised comparison. Oral gefitinib indeed has a similar efficacy to intravenous docetaxel, but better tolerability and quality of life. [...] treating with gefitinib first could be advantageous in providing patients with the opportunity for improved tolerability and quality of life without compromising efficacy.
Publisher
Elsevier Limited
Subject
